2010 - Dutch Cochrane Centre - The Cochrane Collaboration

The Dutch Cochrane Centre 

Annual Report 

2010

Table of Contents 

The Dutch Cochrane Centre - Annual Report 2010 

TABLE OF CONTENTS.....................................................................................1 

ACKNOWLEDGEMENTS ..................................................................................2 

INTRODUCTION ............................................................................................3 

THE DUTCH COCHRANE CENTRE ....................................................................5 

OBJECTIVES....................................................................................................5 

STAFF MEMBERS ..............................................................................................5 

ADVISORY BOARD.............................................................................................6 

FUNDING SUPPORT............................................................................................6 

DUTCH COCHRANE NETWORK CONTACT DETAILS .........................................7 

DUTCH COCHRANE CENTRE..................................................................................7 

BELGIAN BRANCH OF THE DUTCH COCHRANE CENTRE...................................................7 

CHILDHOOD CANCER GROUP ................................................................................7 

FERTILITY REGULATION GROUP .............................................................................8 

PRIMARY HEALTH CARE FIELD...............................................................................8 

REHABILITATION AND RELATED THERAPIES FIELD........................................................8 

ACCOMPLISHMENTS IN RELATION TO THE OBJECTIVES FOR 2010 ...............9 

OBJECTIVE 1...................................................................................................9 

OBJECTIVE 2................................................................................................. 10 

PRESENTATIONS .........................................................................................13 

WORKSHOPS AND COURSES........................................................................15 

COCHRANE REVIEWS WITH A DUTCH SPEAKING FIRST AUTHOR ................17 

PUBLICATIONS RELEVANT TO THE COCHRANE COLLABORATION AND 

EVIDENCE-BASED MEDICINE.......................................................................31 

INTERNATIONAL PUBLICATIONS............................................................................ 31 

COCHRANE PROTOCOLS AND REVIEWS ................................................................... 32 

NATIONAL PUBLICATIONS .................................................................................. 33 

REPORTS ..................................................................................................... 34 

PARTICIPATION IN COCHRANE ENTITIES ...................................................35 

1

Acknowledgements 


Many Dutch and Belgian volunteers actively participate in the activities of The 

Cochrane Collaboration and the Dutch Cochrane Centre. The staff of the Dutch 

Cochrane Centre wishes to express their thanks to all of the many people and 

institutions, both in the Netherlands and abroad, from whom they have received 

guidance and support in 2010. 

We also thank professor Louise Gunning-Schepers and the other members of the 

Board of Directors, and professor Bert Schadé and colleagues, division Clinical 

Methods & Public Health, of the of the Academic Medical Center (AMC), Amsterdam, 

and all members of our Advisory Board for their useful advice and continuous support. 

2

Introduction 



Since October 1994 the Dutch Cochrane Centre is The Cochrane Collaboration’s 

reference centre for The Netherlands, Belgium (handled by the Belgian Branch in 

Leuven), Surinam and the Netherlands' Antilles. The basic ideas of The Cochrane 

Collaboration of identifying all randomised trials, building specialised registers of 

these trials and producing and updating high-quality systematic reviews of the effects 

of all areas of health care, form the basis for its activities. Since 2008, The Cochrane 

Collaboration also facilitates the preparation of systematic reviews about the accuracy 

of diagnostic tests. The Dutch Cochrane Centre collaborates with others to facilitate 

the preparation, maintenance and dissemination of systematic reviews about health 

care interventions and diagnostic tests. 

The Cochrane Collaboration 

The Cochrane Collaboration is an international organisation that aims to help people 

make well-informed decisions about health care by preparing, maintaining and 

promoting the accessibility of systematic reviews of the effects of health care 

interventions and the validity of diagnostic tests. Systematic reviews are reviews 

regarding a well formulated clinical question that use systematic and explicit methods 

to identify, select and critically appraise relevant research, and to collect and analyse 

data from the studies that are included in the review. Cochrane reviews provide upto-date, 

comprehensive and unbiased summaries of the best available evidence of the 

benefits and harms of all types of health care interventions, including preventive, 

therapeutic, rehabilitative, educational and organisational interventions. These 

reviews are published electronically in the Cochrane Library. The Cochrane 

Collaboration’s basic idea of preparing and updating high-quality systematic reviews 

of the effects of health care has been readily accepted throughout the world since its 

start in 1993. More information about The Cochrane Collaboration can be found on 

www.cochrane.org. 

Main issues and activities in 2010 

In this report we present the activities of The Dutch Cochrane Centre in the year 

2010. The main issues were the following. 

- Thirty new protocols for a systematic review and 31 new systematic reviews with a 

Dutch speaking first author were published in the Cochrane Library. The number of 

active reviews and protocols with a Dutch speaking first author in The Cochrane 

Library increased from 284 to 319. 

- We prepared four systematic reviews for the Dutch Health Care Insurance Board 

(College voor Zorgverzekeringen, CvZ) and one systematic review for the Dutch 

Society of Paediatricians. 

- We contributed to a successful grant application for a series of systematic reviews 

for the European Centre for Disease Prevention and Control (ECDC), which was 

initiated by the KNCV Tuberculosis Foundation. 

- The Netherlands Trial Register (NTR), one of the first primary registers recognised 

by the WHO, now encompasses over 2700 trials. 

- We produced eleven summaries of new or updated Cochrane reviews for the 

Nederlands Tijdschrift voor Geneeskunde (Dutch Medical Journal). 

3


- In 2010, four workshops “Developing a systematic review” were given. We 

organised a total of 23 courses and workshops about evidence-based medicine and 

systematic reviews. There were over 850 participants. 

- The Continental Europe Support Unit ran one induction training session for The 

South African Cochrane Centre in Cape Town, South Africa. In collaboration with 

the UK Support Unit we organised the third (two-day) workshop “Cochrane 

Systematic Reviews of Diagnostic Test Accuracy” for authors of Cochrane reviews. 

- On December 14, we co-organised the tenth Annual Dutch Cochrane Contributors 

Meeting. This year’s topic was Publication Bias in Clinical and Laboratory Animal 

Research and prof. Kay Dickersin was the invited speaker. This masterclass was 

followed by a “Ruysch-lecture” of which dr. Gerben ter Riet was the host. 

- On January 1 st , Rob Scholten has been appointed as professor of Evidence-Based 

Medicine by the University of Amsterdam. 

- In October, the Cochrane Collaboration Steering Group appointed Dr. Menno van 

Leeuwen, member of the DCC’s Advisory Board, as Ombudsman. 

- In October, Rob Scholten retired from the Cochrane Collaboration Steering Group 

after having served for two terms (six years). 

- In October, Rob Scholten was appointed as Director of The Cochrane Collaboration 

Trading Company (with Lorne Becker and Jon Deeks). 

- René Spijker joined the Cochrane Trial Search Coordinators’ Executive and Rob 

Scholten joined the Centre Directors’ Executive. 

- Rob Scholten joined the Monitoring and Evaluation (M&E) subgroup of the WHO 

Nutrition Guidance Expert Advisory Group (NUGAG), which the WHO Department of 

Nutrition for Health and Development (NHD) has formed for the development of 

WHO guidelines in the area of evidence-based guidelines for nutritional status 

assessment and monitoring and evaluation of nutrition programmes. 

4


OBJECTIVES 


Objective 1 

To stimulate and support evidence-based medicine activities in the Netherlands to 

help professionals and consumers to make well-informed decisions about health care. 

Activities 

1.1 To support the use of evidence-based medicine in Dutch health care. 

1.2 To train medical professionals in evidence-based medicine. 

Objective 2 

To contribute to The Cochrane Collaboration to support evidence-based medicine. 

Activities 

2.1 To support and to stimulate the preparation of high quality Cochrane 

systematic reviews about health care interventions and diagnostic test 

accuracy. 

2.2 To contribute to The Cochrane Collaboration and to maintain an adequate 

infrastructure for The Dutch Cochrane Centre. 

2.3 To identify scientific publications (evidence) about the efficacy of healthcare 

interventions. 

STAFF MEMBERS 

In 2010, Annefloor van Enst (March 1 st ) and Esther van de Glind (June 14 th ) joined 

our team. Annefloor has an MSc in Health Sciences and works as a junior researcher 

for our Systematic Review Unit. In addition, she will work on a PhD thesis. Esther has 

interrupted her training as geriatrist and will conduct a PhD project regarding 

empirical methods for evidence-based geriatrics. 

Lotty Hooft was employed for 0.5 FTE with the Netherlands Trial Register, a project 

funded by ZonMw (the Dutch MRC). 

Lotty Hooft (0.1 FTE), Mariska Leeflang (0.1), Hans Reitsma (0.1) and Rob Scholten 

(0.1) partially worked for the Continental Europe Support Unit (CESU) funded by The 

Cochrane Collaboration. The aim of CESU is to help Cochrane Review Groups based 

on the European continent with the implementation of Cochrane Diagnostic test 

accuracy reviews. 

The current staff consists of 0.7 FTE administrative staff and 6.1 FTE scientific staff 

(partially employed on external resources, mostly from commissioned reviews). 

5


Overview of staff members of The Dutch Cochrane Centre (2010) 

Name Appointment FTE Unit(s) 

Roy Elbers Junior scientific staff member 0.7 DCC, SR Unit 

Annefloor van Enst Junior scientific staff member / PhD student 1.0 DCC, SR Unit 

Esther van de Glind Junior scientific staff member / PhD student 1.0 DCC 

Lotty Hooft Senior scientific staff member 1.0 DCC, NTR, 

CESU, SR Unit 

Sharon Kramer Junior scientific staff member 0.9 DCC, SR Unit 

Miranda Langendam Senior scientific staff member 0.9 DCC, SR Unit 

Mariska Leeflang Post-doc 0.1 CESU 

Jacqueline Limpens Information specialist 0.2 DCC, SR Unit 

Hans Reitsma Senior scientific staff member 0.1 CESU 

Rob Scholten Director 1.0 DCC, CESU, 

SR Unit 

René Spijker Information specialist 0.2 DCC, SR Unit 

Hanni Spitteler Administrator 0.7 DCC, CESU 

* The Netherlands Trial Register (NTR), Continental Europe Support Unit (CESU) and the 

SR Unit are externally funded projects. 

ADVISORY BOARD 

The Advisory Board of the Dutch Cochrane Centre provides overall guidance in all 

matters related to the work of the Centre to accomplish, as efficiently as possible, the 

goals of The Cochrane Collaboration. The current members of the Advisory Board are: 

Name Affiliation 

A.J.P.M. Overbeke Centre for Evidence Based Practice, Nijmegen University, 

Nijmegen (Chair) 

H.J.B.M. Abeln Twynstra Gudde Management Consultants, Amersfoort 

R.A. de Bie Department of Epidemiology, Maastricht University, Maastricht 

P.M.M. Bossuyt Department of Clinical Epidemiology, Biostatistics and 

Bioinformatics, Academic Medical Center, Amsterdam 

F. Buntinx Department of General Practice Leuven/Maastricht 

F.M. Helmerhorst Department of Gynaecology and Obstetrics, Leiden University 

Medical Center, Leiden 

M. van Leeuwen Former secretary of the Netherlands Health Council, Naarden 

S. Middeldorp Department of Vascular Medicine, Academic Medical Center, 

Amsterdam 

M. Offringa Paediatric Clinical Epidemiology, Emma Children’s Hospital / 

Academic Medical Center, Amsterdam 

I. Thomassen-Hilgersom Dutch Society of Patients with Posttraumatic Dystrophia, 

Nijmegen 

H.C.W. de Vet EMGO Institute, VU medical center, Amsterdam 

A. Wijbenga Netherlands Health Council, The Hague 

FUNDING SUPPORT 

The Dutch Cochrane Centre has been granted structural funding from the Dutch 

Ministry of Health, while the Academic Medical Center offered much in kind support to 

the Centre. 

6


Dutch Cochrane Network Contact Details 

DUTCH COCHRANE CENTRE 

Mrs J.A.M. Spitteler 

Dutch Cochrane Centre 

Academic Medical Center, J1B - 226 

PO Box 22700 

1100 DE AMSTERDAM 

The Netherlands 

Phone: +31 20 5665602 

Fax: +31 20 6912683 

E-mail: cochrane@amc.uva.nl 

Website: www.cochrane.nl 

BELGIAN BRANCH OF THE DUTCH COCHRANE CENTRE 

Dr Hans Van Brabandt, director 

Ms E. Vanachter & Mrs. Y. Libens, administrators 

CEBAM 

Kapucijnenvoer 33 - blok J bus 7001 

3000 LEUVEN 

Belgium 

Phone: +32 16 332697 

Fax: +32 16 337480 

E-mail: info@cebam.be 

Website: www.cebam.be 

CHILDHOOD CANCER GROUP 

Dr L.C.M. Kremer, co-ordinating editor 

Dr E.C. van Dalen, managing editor 

Mrs J.K. Noorman, assistant managing editor 

Dr.ir. E. Leclercq, trial search coordinator 

Emma Children's Hospital / Academic Medical Center 

PO Box 22700 

1100 DE AMSTERDAM 


Phone: +31 20 5666370 

Fax: +31 20 6912231 

E-mail: chcrg@amc.uva.nl 

Website: www.ccg.cochrane.org 

7


FERTILITY REGULATION GROUP 

Prof.dr. F.M. Helmerhorst, co-ordinating editor 

Mrs. A.H.C. Helmerhorst-van Altena, managing editor 

Leiden University Medical Center 

Department of Gynaecology & Reproductive Medicine, Postal Zone: P-K6 

PO Box 9600 

2300 RC LEIDEN 


Phone: +31 71 3013182 

Phone 2: +31 71 3013705 

Fax: +31 71 3012822 

E-mail: ahelmerhorst@lumc.nl 

Website: www.lumc.nl/1060/cochrane 

PRIMARY HEALTH CARE FIELD 

Prof J. van Binsbergen and dr F. van de Laar, co-convenors 

(with colleagues from New Zealand and Ireland) 

Ms T. Pouwels, secretary 

Radboud University Nijmegen Medical Centre 

Dpt. of Primary and Community Care 

117 P.O. Box 9101 

6500 HB NIJMEGEN 


Phone: +31 24 3667332 

Fax: +31 24 354 1862 

E-mail: info@cochraneprimarycare.org 

Website: www.cochraneprimarycare.org 

REHABILITATION AND RELATED THERAPIES FIELD 

Prof R.A. de Bie, convenor 

Department of Epidemiology 

Maastricht University 

PO Box 616 

6200 MD MAASTRICHT 


Phone: +31 43 3882362 

Fax: +31 43 3884128 

E-mail: ra.debie@epid.unimaas.nl 

Website: www.cebp.nl 

8


Accomplishments in Relation to the Objectives for 2010 

OBJECTIVE 1 

To stimulate and support evidence-based medicine activities in the Netherlands to 

help professionals and consumers to make well-informed decisions about health care. 

Activity 1.1 

To support the use of evidence-based medicine in Dutch health care. 

Accomplishments 

- We prepared four systematic reviews for the Dutch Health Care Insurance Board (College 

voor Zorgverzekeringen, CvZ) and one systematic review for the Dutch Society of 

Paediatricians. 

- We produced a systematic summary of the value of diagnostic instruments for a guideline 

working group regarding autism spectrum disorders, chaired by the Trimbos Institute. 

- We contributed to a successful grant application for a series of systematic reviews for the 

European Centre for Disease Prevention and Control (ECDC), which was initiated by the 

KNCV Tuberculosis Foundation. 

- We contributed to a successful grant application for a project regarding the use of n of 1 

trials, led by the Vereniging Spierziekten Nederland. 

- We produced eleven summaries of new or updated Cochrane reviews for the Nederlands 

Tijdschrift voor Geneeskunde (Dutch Medical Journal). 

- For the Quality of Care Council (Regieraad Kwaliteit van Zorg) Rob Scholten participated 

in a working group that developed a guideline for guidelines. 

- Rob Scholten continued his membership of the Advisory Committee of Nederlands 

Kenniscentrum Farmacotherapie bij Kinderen (NKFK) and joined HARING (led by IQ 

Healthcare), a project that aims to produce tools for guideline developers. 

- Lotty Hooft, Mariska Leeflang and Rob Scholten joined a working group to develop and 

promote systematic reviews of laboratory animal studies. 

- Lotty Hooft and Esther van de Glind supported a guideline working group regarding 

resuscitation of elderly (chaired by VERENSO). 

- Miranda Langendam participated in the Dutch GRADE Working Group. 

- Rob Scholten attended two Invitational Conferences organised by WB-Zorg / 

Kwaliteitsinstituut voor de Gezondheidszorg CBO and IQ Healthcare) and two Working 

Conferences organised by Health Services Research in Europe and CvZ. 

- Staff members of the Dutch Cochrane Centre were advisors of and participated in the 

“EBRO-platform”, which consists of representatives of almost all Dutch entities that are 

involved with guideline development, and of various other scientific and advisory 

committees. 

9

Activity 1.2 


To train medical professionals in evidence-based medicine. 


- In 2010, we organised 23 courses and workshops about evidence-based medicine and 

systematic reviews. There were over 850 participants. See page 15 for an overview. 

- For the second year we ran an EBM module for the Nederlands Kenniscentrum 

Verzekeringsgeneeskunde (KCVG). 

- We worked with various Dutch health care institutions (among which the 

Kwaliteitsinstituut voor de Gezondheidszorg CBO and various scientific societies) to run 

in-house courses on EBM and Evidence-based Guideline Development. See page 15 for 

an overview. 

OBJECTIVE 2 

To contribute to The Cochrane Collaboration to support evidence-based medicine. 

Activity 2.1 

To support and to stimulate the preparation of high quality Cochrane systematic reviews 

about health care interventions. 


- Thirty new protocols for a systematic review and 31 new systematic reviews with a Dutch 

speaking first author were published in the Cochrane Library. The number of active 

reviews and protocols with a Dutch speaking first author in The Cochrane Library 

increased from 284 to 319 (see page 17). 

- Four workshops “Developing a systematic review” were given. A total number of 72 

participants attended. 

- The Continental Europe Support Unit ran one induction training session for the South 

African Cochrane Centre. 

- The UK and Continental Europe Support Units organised the third (two-day) workshop 

“Cochrane Systematic Reviews of Diagnostic Test Accuracy” for authors of Cochrane 

reviews. There were 37 participants. 

- In collaboration with many other Cochranites, staff members of the DCC ran various 

workshops regarding Diagnostic test accuracy reviews at the Colloquium in Keystone (15- 

50 participants per workshop). 

- For the Cochrane Diagnostic Test Accuracy Editorial Team we peer-reviewed over 30 

protocols and/or reviews. 

- On December 14, we co-organised the tenth Annual Dutch Cochrane Contributors 

Meeting. This year’s topic was Publication Bias in Clinical and Laboratory Animal Research 

and prof. Kay Dickersin was the invited speaker. This masterclass was followed by a 

“Ruysch-lecture” of which dr. Gerben ter Riet was the host. There were 93 participants. 

- We answered on average 5-10 queries per week by phone or e-mail. Approximately 40 

persons visited the Dutch Cochrane Centre for consultation. 

10

Activity 2.2 


To contribute to The Cochrane Collaboration and to maintain an adequate infrastructure for 

the Dutch Cochrane Centre. 


- To promote The Cochrane Collaboration and evidence-based medicine we published 44 

articles (page 31) and gave 25 presentations (page 13). 

- Staff members of the DCC participated in 66 Cochrane entities (see page 35). 

- The Netherlands Trial Register encompasses over 2700 trials. 

- Lotty Hooft was Chair of the WHO Working Group on Best Practice for Clinical Trials 

Registers (http://www.who.int/ictrp/network/bpg/en/index.html). 

- Lotty Hooft continued to participate in an EU project regarding the development of an 

European Health Technology Assessment network (EUnetHTA). 

- Rob Scholten joined the Monitoring and Evaluation (M&E) subgroup of the WHO Nutrition 

Guidance Expert Advisory Group (NUGAG). This Group’s remit is to develop evidencebased 

WHO guidelines for nutritional status assessment and monitoring and evaluation 

of nutrition programmes. 

- Mariska Leeflang continued her co-convenorship of the Cochrane Screening and 

Diagnostic Tests Methods Group. 

- In October, the Cochrane Collaboration Steering Group appointed Dr. Menno van 

Leeuwen, member of the DCC’s Advisory Board, as Ombudsman. 

- In October, Rob Scholten retired from the Cochrane Collaboration Steering Group after 

having served for two terms (six years). 

- In October, Rob Scholten was appointed as Director of The Cochrane Collaboration 

Trading Company (with Lorne Becker and Jon Deeks). 

- René Spijker joined the Cochrane Trial Search Coordinators’ Executive and Rob Scholten 

the Centre Directors’ Executive. 

- Upon request of various foreign colleagues we assessed Dutch articles. In addition, we 

retrieved various Dutch articles and reports that were not readily available outside the 

Netherlands. 

- We maintain a database of over 1800 individuals who have shown interest in the 

activities of The Cochrane Collaboration. We have sent out regular mailings, including the 

Cochrane newsletter and information regarding the Cochrane Colloquium. 

- Our website was kept up-to-date and was visited over 26,000 times. 

Activity 2.3 

To identify scientific publications (evidence) about the efficacy of healthcare interventions. 


- In 2010, we handsearched various medical journals. 

11

Number 

350 

300 

250 

200 

150 

100 

50 

0 


Cochrane Protocols and Systematic Reviews with a Dutch-speaking first author 

11 

23 

29 

27 

35 

39 

47 

48 54 51 

12 

58 

77 

94 

118 

134 

155 

158 

189 

215 

74 74 70 77 82 89 95 99 

1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 

Year 

Protocols Reviews Protocols + Reviews

Presentations 

Annefloor van Enst 


21 September Extending the search to find ongoing and unpublished trials: a 

survey of methods and results of Cochrane reviews. Presentation, 

seminar, Department of Clinical Epidemiology, AMC, Amsterdam. 

22 October Extending the search to find ongoing and unpublished trials: a 

survey of methods and results of Cochrane reviews. Presentation, 

Cochrane Colloquium, Keystone, Colorado, USA. 

17 December Evidence Based Medicine for physiotherapists and orthopaedics. 

Bijscholingsproject voor Anna Tommie. KNVB Sportcentrum, Zeist. 

Roy Elbers 

18-22 October The assessment of fatigue in multiple sclerosis, Parkinson’s disease 

and stroke: a systematic review of measurement properties. Poster 

presentation, Cochrane Colloquium, Keystone, Colorado, USA. 

Lotty Hooft 

2 February Evidence-based medicine in geriatric medicine. Project presentation 

for the Board of directors (RvB) AMC, Amsterdam. 

3 June Netherlands Trial Register (NTR): History and Future. Presentation 

for ZonMW, Den Haag. 

11 November Netherlands Trial Register (NTR); an update. Presentation for the 

WHO Best Practice Group. Meeting of the Registry Network of the 

ICTRP, Geneva, Switzerland. 

11 November WHO Meeting of the Registry Network of the ICTRP Geneva Meeting. 

Chair, International Standards and Data Quality. 

2 December Critical reading of scientific literature. Presentation for “EBM: Can’t 

live with it and can’t live without it.” Symposium of emergency room 

specialists, Den Haag. 

14 December Ruysch Minisymposium “Publication Bias in Clinical and Laboratory 

Animal Research”, AMC. Chair of session “Clinical Research”. 

Miranda Langendam 

19 October GRADE: reasons for downgrading the quality of evidence in recent 

Cochrane Reviews. Presentation, Cochrane Colloquium, Keystone, 

USA. 

Mariska Leeflang 

25 February Invited lunch seminar at the Institute of Tropical Medicine in 

Antwerp, Belgium; “Systematic Reviews of Diagnostic Test 

Accuracy”. 

13


1 July Sensitivity and specificity rarely vary with prevalence. Presentation, 

Symposium on Methods for Evaluating Medical Tests and 

Biomarkers, Birmingham, UK. 

2 July Bivariate meta-analysis of predictive values. Presentation, 

Symposium on Methods for Evaluating Medical Tests and 

Biomarkers, Birmingham, UK. 

28 July Diagnostic systematic reviews. Presentation, AIOS Internal 

Medicine, AMC, Amsterdam. 

20 October Sensitivity and specificity rarely vary with prevalence. Poster 

presentation, Cochrane Colloquium, Keystone, Colorado, USA. 

22 October Bivariate meta-analysis of predictive values. Oral presentation, 

Cochrane Colloquium, Keystone, Colorado, USA. 

Rob Scholten 

8 April Workshop Systematic reviews of organisational interventions. Panel 

member, Working Conference Health Services Research in Europe, 

The Hague. 

19 May Vrijheid om af te wijken. Invitational conference, WB-Zorg and CBO, 

The Hague. 

16 June Systematic reviews: a comparison to the clinical field: The Cochrane 

Collaboration. Presentation, Federation of Laboratory Animal 

Science Associations (FELASA), Helsinki, Finland. 

28 July When is evidence evidence [Wanneer is bewijs bewijs?]? 

Presentation, AIOS Internal Medicine, AMC, Amsterdam. 

27 September HARING. Invitational conference, IQ Health Care, Utrecht. 

19 October Session Design and Methods. Chair, Cochrane Colloquium, 

Keystone, USA. 

9 November Medische tests. Working Conference, College voor 

Zorgverzekeringen, Diemen. 

14

Workshops and Courses 


27-29 January Evidence-based medicine in clinical practice. Course, Dutch 

Cochrane Centre, Amsterdam. 

1 March Developing a systematic review. Workshop, Dutch Cochrane 

18 May Centre, Amsterdam. 

20 September 

23 November 

17 March Module Systematic Reviews (5 days). Evidence-based practice 

– 14 April master programme (2 nd year), Amsterdam. 

11 May – Critical appraisal. Five lectures for “EBM for Health 

7 December Insurance Physicians”, Research Center for Insurance Medicine, 

Amsterdam. 

12-17 May Critical appraisal of systematic reviews. Various workshops for 

undergraduates, AMC, Amsterdam. 

26 May Critical appraisal of medical literature for evidence-based guideline 

development (EBRO). Course, CBO, Utrecht. 

27 May Module Systematic Reviews (5 days). Evidence-based practice 

– 24 June master programme (1 st year), Amsterdam. 

31 May Evidence-based searching for physicians and librarians. Course, 

Medical Library AMC / Dutch Cochrane Centre, Amsterdam. 

16-17 August Induction training Diagnostic Test Accuracy reviews. South African 

Cochrane Centre and South African Branch of Cochrane HIV/AIDS 

Group, Cape Town, South Africa. 

18 August Module Diagnostic Test Accuracy reviews. Masters Clinical 

Epidemiology, Cape Town, South Africa. 

9-10 September Two-day workshop Systematic reviews of diagnostic test 

accuracy for review authors, Amsterdam. 

11 October Systematic reviews. Lecture for medical students (3 rd yr), AMC, 

Amsterdam. 

14 October What is evidence based medicine? Workshop. AIOS Cardiology, 

Utrecht. 

22 October Systematic reviews of diagnostic test accuracy studies: 3. Quality 

Assessment. Workshop, Cochrane Colloquium, Keystone, Colorado, 

USA. 

22 October Systematic reviews of diagnostic test accuracy studies: 6. 

Presenting and interpreting results. Workshop, Cochrane 

Colloquium, Keystone, Colorado, USA. 

3 November AMC World of Science. Various workshops, AMC Graduate School, 

Amsterdam. 

15


4 November Critical appraisal of medical literature for evidence-based guideline 

development (EBRO). In-company course, NVALT (Nederlandse 

Vereniging van Artsen voor Longziekten en Tuberculose), Utrecht. 

29 November Systematic reviews. Course, Epidemiology and statistics 

- 1 December programme for medical information students, AMC, Amsterdam. 

8 December Evidence based literature searching for The Dutch Health Council. 

Workshop, AMC, Amsterdam. 

14 December Annual Dutch Cochrane Contributors’ Meeting. Various workshops, 

Dutch Cochrane Centre, Amsterdam. 

16


Cochrane Reviews with a Dutch speaking First Author 

Acute Respiratory Infections Group 

1. Blom D, Ermers M, Bont L, Woensel JBM van, Aalderen WMC van. Inhaled 

corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic 

wheezing. 

2. Brouwer MC, McIntyre P, Gans J de, Prasad K, Beek D van de. Corticosteroids for 

acute bacterial meningitis. 

3. Driel ML van, De Sutter An IM, Keber N, Habraken H, Christiaens T. Different 

antibiotic treatments for group A streptococcal pharyngitis. 

4. Duijvestijn Yvonne CM, Mourdi N, Smucny J, Pons G, Chalumeau M. Acetylcysteine 

and carbocysteine for acute upper and lower respiratory tract infections in 

paediatric patients without chronic broncho-pulmonary disease. 

5. Jansen Angelique GSC, Hak Eelko, Veenhoven Reinier H, Damoiseaux Roger AMJ, 

Schilder Anne GM, Sanders Elisabeth AM . Pneumococcal conjugate vaccines for 

preventing otitis media. 

Airways Group 

1. Tanja Maas, Janneke Kaper, Aziz Sheikh, André J Knottnerus, Geertjan Wesseling, 

Edward Dompeling, Jean WM Muris, Constant Paul van Schayck. Mono and 

multifaceted inhalant and/or food allergen reduction interventions for preventing 

asthma in children at high risk of developing asthma. 

2. Meer RM van der, Wagena E, Ostelo RWJG, Jacobs JE, Schayck CP van. Smoking 

cessation for chronic obstructive pulmonary disease. 

3. Effing T, Monninkhof EM, Valk PDLPM van der, Zielhuis GA, Walters EH, Palen J 

van der. Self-management education for patients with chronic obstructive 

pulmonary disease. 

4. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJPM, Hooft L, Bijlmer 

HA, et al. Galactomannan detection for invasive aspergillosis in 

immunocompromized patients. 

5. van der Wouden JC, Uijen Johannes HJM, Bernsen Roos MD, Tasche Marjolein JA, 

de Jongste JC, Ducharme FM. Inhaled sodium cromoglycate for asthma in 

children. 

6. Wijkstra PJ, Lacasse Y, Guyatt GH, Goldstein RS, Struik F. Nocturnal non-invasive 

positive pressure ventilation for stable chronic obstructive pulmonary disease. 

Back Group 

1. Assendelft WJJ, Morton SC, Yu Emily I, Suttorp MJ, Shekelle PG. Spinal 

manipulative therapy for low-back pain. 

2. van Duijvenbode I, Jellema P, van Poppel M, van Tulder MW. Lumbar supports for 

prevention and treatment of low back pain. 

3. Engers AJ, Jellema P, Wensing M, Windt DAWM van der, Grol R, Tulder MW van. 

Individual patient education for low back pain. 

4. Henschke N, Ostelo Raymond WJG, van Tulder MW, Vlaeyen Johan WS, Morley S, 

Assendelft Willem JJ, et al. Behavioural treatment for chronic low-back pain. 

5. Heymans M, Tulder MW van, Esmail R, Bombardier C, Koes BW. Back schools for 

non-specific low-back pain. 

17


6. Jacobs WCH, Anderson PG, Limbeek van J, Willems PC, Pavlov P. Single or doublelevel 

anterior interbody fusion techniques for cervical degenerative disc disease. 

7. Ostelo RWJG, Costa LOP, Maher CG, Vet HCW de, Tulder MW van. Rehabilitation 

after lumbar disc surgery. 

8. Roelofs Pepijn DDM, Deyo RA, Koes BW, Scholten Rob JPM, van Tulder MW. Nonsteroidal 

anti-inflammatory drugs for low back pain. 

9. Tulder MW van, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for 

non-specific low-back pain. 

10. Verhagen AP, Scholten-Peeters GGGM, Wijngaarden S van, Bie RA de, Bierma- 

Zeinstra SMA. Conservative treatments for whiplash. 

11. van der Windt Daniëlle AWM, Simons E, Riphagen I, Ammendolia C, Verhagen AP, 

Laslett M, et al. Physical examination for lumbar radiculopathy due to disc 

herniation in patients with low-back pain. 

Bone, Joint and Muscle Trauma Group 

1. Heintjes EM, Berger M, Bierma-Zeinstra SMA, Bernsen RMD, Verhaar JAN, Koes 

BW. Exercise therapy for patellofemoral pain syndrome. 

2. Heintjes EM, Berger M, Bierma-Zeinstra SMA, Bernsen RMD, Verhaar JAN, Koes 

BW. Pharmacotherapy for patellofemoral pain syndrome. 

3. Hofstad CJ, Linde H van der, Limbeek J van, Postema K. Prescription of prosthetic 

ankle-foot mechanisms after lower limb amputation. 

4. Kerkhoffs GMMJ, Struijs PAA, Marti RK, Assendelft WJJ, Blankevoort L, Dijk CN 

van. Different functional treatment strategies for acute lateral ankle ligament 

injuries in adults. 

5. Kerkhoffs GMMJ, Rowe BH, Assendelft WJJ, Kelly K, Struijs PAA, Dijk CN van. 

Immobilisation and functional treatment for acute lateral ankle ligament injuries in 

adults. 

6. Kerkhoffs GMMJ, Handoll HHG, Bie R de, Rowe BH, Struijs PAA. Surgical versus 

conservative treatment for acute injuries of the lateral ligament complex of the 

ankle in adults. 

7. Krul M, van der Wouden JC, van Suijlekom-Smit LWA, Koes BW. Manipulative 

interventions for reducing pulled elbow in young children. 

8. Poolman RW, Goslings JC, Lee J, Statius Muller M, Steller EP, Struijs PAA. 

Conservative treatment for closed fifth (small finger) metacarpal neck fractures. 

9. Vries JS de, Krips R, Sierevelt IN, Blankevoort L, Dijk CN van. Interventions for 

treating chronic ankle instability. 

10. Windt DAWM van der, Heijden GJ van der, Berg S van den, Riet G ter, Winter AF 

de, Bouter LM. Therapeutic ultrasound for acute ankle sprains. 

Breast Cancer Group 

1. Hage JH van der, Velde CJH van de, Mieog JSD. Preoperative chemotherapy for 

women with operable breast cancer. 

Childhood Cancer Group 

1. Admiraal R, van der Paardt M, Kobes J, Kremer Leontien CM, Bisogno G, Merks 

Johannes HM. High-dose chemotherapy for children and young adults with stage 

IV rhabdomyosarcoma. 

2. van Dalen EC, Beatriz de Camargo. Methotrexate for high-grade osteosarcoma in 

children and young adults. 

18


3. van Dalen EC, Raphaël MF, Caron HN, Kremer Leontien CM. Treatment including 

anthracyclines versus treatment not including anthracyclines for childhood cancer. 

4. Goossen GM, Kremer Leontien CM, Wetering MD van de. Influenza vaccination in 

children being treated with chemotherapy for cancer. 

5. de Lijster MS, Bergevoet RM, van Dalen EC, Michiels Erna MC, Caron HN, Kremer 

Leontien CM, et al. Minimally invasive surgery versus open surgery for the 

treatment of solid abdominal and thoracic neoplasms in children. 

6. Mulder RL, Paulides M, Langer T, Kremer Leontien CM, van Dalen EC. 

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft 

tissue sarcoma patients. 

Colorectal Cancer Group 

1. Ahmed Ali U, Keus F, Heikens JT, Bemelman WA, Berdah SV, Gooszen HG, 

Laarhoven CJHM van. Open versus laparoscopic (assisted) ileo pouch anal 

anastomosis for ulcerative colitis and familial adenomatous polyposis. 

2. Breukink S, Pierie JP, Wiggers T. Laparoscopic versus open total mesorectal 

excision for rectal cancer. 

3. Ceelen WP, Nieuwenhove Y van, Fierens K. Preoperative chemoradiation versus 

radiation alone for stage II and III resectable rectal cancer. 

4. Haas-Kock DFM de, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, 

Mastrigt GAPG, et al. Concomitant hyperthermia and radiation therapy for treating 

locally advanced rectal cancer. 

5. Hartog D den, Dur AHM, Tuinebreijer WE, Kreis RW. Open surgical procedures for 

incisional hernias. 

6. Nienhuijs SW, Hingh IHJT de. Conventional versus LigaSure hemorrhoidectomy for 

patients with symptomatic Hemorrhoids. 

Consumers and Communication Group 

1. Mistiaen P, Poot E. Telephone follow-up, initiated by a hospital-based health 

professional, for postdischarge problems in patients discharged from hospital to 

home. 

2. Wetzels R, Harmsen M, Weel C van, Grol R, Wensing M. Interventions for 

improving older patients' involvement in primary care episodes. 

Cystic Fibrosis and Genetic Disorders Group 

1. Schans C.P. van der, Prasad A, Main E. Chest physiotherapy compared to no chest 

physiotherapy for cystic fibrosis. 

Dementia and Cognitive Improvement Group 

1. Angevaren M, Aufdemkampe G, Verhaar HJJ, Aleman A, Vanhees L. Physical 

activity and enhanced fitness to improve cognitive function in older people without 

known cognitive impairment. 

2. Vink AC, Birks J, Bruinsma MS, Scholten RJPM. Music therapy for people with 

dementia. 

19


Depression, Anxiety and Neurosis Group 

1. Boer PCAM den, Wiersma D, Russo S, Bosch RJ. Paraprofessionals for anxiety and 

depressive disorders. 

2. Henken T, Huibers MJH, Churchill R, Restifo KK, Roelofs JJ. Family therapy for 

depression. 

3. Hoedeman R, Blankenstein AH, Feltz-Cornelis CM van der, Krol B, Stewart R, 

Groothoff JW. Consultation letters for medically unexplained physical symptoms in 

primary care. 

4. Huibers MJH, Beurskens A, Bleijenberg G, Schayck OP van. Psychosocial 

interventions by general practitioners. 

5. Nieuwenhuijsen K, Bültmann U, Neumeyer-Gromen A, Verhoeven AC, Verbeek JH, 

Feltz-Cornelis CM van der. Interventions to improve occupational health in 

depressed people. 

6. Stek ML, Wurff FFB van der, Hoogendijk WJG, Beekman ATF. Electroconvulsive 

therapy for the depressed elderly. 

7. Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA. Pharmacological treatment for 

psychotic depression. 

Ear, Nose and Throat Disorders Group 

1. Van den Aardweg Maaike TA, Schilder Anne GM, Herkert E, Boonacker Chantal 

WB, Rovers MM. Adenoidectomy for otitis media in children. 

2. Van den Aardweg Maaike TA, Schilder Anne GM, Herkert E, Boonacker Chantal 

WB, Rovers MM. Adenoidectomy for recurrent or chronic nasal symptoms in 

children. 

3. Lambin Philippe , Ramaekers Bram LT, van Mastrigt Ghislaine APG , Van den Ende 

P , de Jong J , De Ruysscher Dirk K M , Pijls Johannesma Madelon Erythropoietin 

as an adjuvant treatment with (chemo) radiation therapy for head and neck 

cancer. 

4. Pullens B, Giard JL, Verschuur HP, van Benthem PP. Surgery for Ménière's disease. 

5. Verschuur HP, Wever W de, Benthem PP van. Antibiotic prophylaxis in clean and 

clean-contaminated ear surgery. 

Effective Practice and Organisation of Care Group 

1. Laurant M, Reeves D, Hermens R, Braspenning J, Grol R, Sibbald B. Substitution 

of doctors by nurses in primary care. 

2. Renders CM, Valk GD, Griffin SJ, Wagner E, Eijk JTM van, Assendelft WJJ. 

Interventions to improve the management of diabetes mellitus in primary care, 

outpatient and community settings. 

3. Tanja-Dijkstra K, Pieterse ME. The psychological effects of the physical healthcare 

environment on healthcare personnel. 

Epilepsy Group 

1. Koch MW, Polman SKL. Oxcarbazepine versus carbamazepine monotherapy for 

partial onset seizures. 

20

Fertility Regulation Group 


1. Helmerhorst FM, Vliet HAAM van, Gornas T, Finken MJ, Grimes DA. Intra-uterine 

insemination versus timed intercourse or expectant management for cervical 

hostility in subfertile couples. 

2. Visser J, Snel M, Vliet HAAM van. Hormonal versus non-hormonal contraceptives 

in women with diabetes mellitus type 1 and 2. 

3. Vliet HAAM van, Grimes DA, Helmerhorst FM, Schulz KF, Lopez LM. Biphasic 

versus monophasic oral contraceptives for contraception. 

4. Vliet HAAM van, Grimes DA, Helmerhorst FM, Schulz KF, Lopez LM. Biphasic 

versus triphasic oral contraceptives for contraception. 

5. Van Vliet Huib AAM, Grimes DA, Lopez LM, Schulz KF, Helmerhorst FM. Triphasic 

versus monophasic oral contraceptives for contraception. 

6. Wijden C van der, Brown J, Kleinen J. Lactational amenorrhea for family planning. 

Gynaecological Cancer Group 

1. Ansink A, Stegeman M, Velden J van der, Collingwood M. Surgical interventions for 

early squamous cell carcinoma of the vulva. 

2. Baalbergen A, Veenstra Y, Stalpers LL, Ansink AC. Primary surgery versus primary 

radiation therapy with or without chemotherapy for early adenocarcinoma of the 

uterine cervix. 

3. Dalen EC van, Caron HN, Dickinson HO, Kremer LCM. Cardioprotective 

interventions for cancer patients receiving anthracyclines. 

4. Dalen EC van, Michiels Erna MC, Caron HN, Kremer Leontien CM. Different 

anthracycline derivates for reducing cardiotoxicity in cancer patients. 

5. Dalen EC van, Pal HJH van der, Caron HN, Kremer LCM. Different dosage 

schedules for reducing cardiotoxicity in cancer patients receiving anthracycline 

chemotherapy. 

6. Doorn HC van, Ansink A, Verhaar-Langereis MMJ, Stalpers LL. Neoadjuvant 

chemoradiation for advanced primary vulvar cancer. 

7. Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief K, et al. Antigenspecific 

active immunotherapy for ovarian cancer. 

8. Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock Danielle FM, Buijsen 

J, Mastrigt Ghislaine APG, et al. Combined use of hyperthermia and radiation 

therapy for treating locally advanced cervical carcinoma. 

9. Velden J van der, Ansink A. Primary groin irradiation versus primary groin surgery 

for early vulvar cancer. 

10. Wetering MD van de, Woensel JBM van. Prophylactic antibiotics for preventing 

early central venous catheter Gram positive infections in oncology patients. 

Heart Group 

1. Keller T, Weeda VB, Dongen CJ van, Levi M. Influenza vaccines for preventing 

coronary heart disease. 

2. Oude Luttikhuis Hiltje , Baur Louise , Jansen Hanneke , Shrewsbury Vanessa A, 

O'Malley Claire , Stolk Ronald P , Summerbell Carolyn D Interventions for treating 

obesity in children. 

21

Hepato-Biliary Group 


1. Keus F, Gooszen HG, van Laarhoven Cornelis JHM. Open, small-incision, or 

laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An 

overview of Cochrane Hepato-Biliary Group reviews. 

2. Keus F, Jong J de, Gooszen HG, Laarhoven CJHM van. Laparoscopic versus smallincision 

cholecystectomy for patients with symptomatic cholecystolithiasis. 

3. Keus F, Jong J de, Gooszen HG, Laarhoven CJHM van. Laparoscopic versus open 


4. Keus F, Jong J de, Gooszen HG, Laarhoven CJHM van. Small-incision versus open 


Incontinence Group 

1. Deutekom M, Dobben AC. Plugs for containing faecal incontinence. 

2. Niël-Weise BS, Broek PJ van den. Urinary catheter policies for long-term bladder 

drainage. 

3. Niël-Weise BS, Broek PJ van den. Urinary catheter policies for short-term bladder 

drainage in adults. 

4. Niël-Weise BS, Broek PJ van den. Antibiotic policies for short-term catheter 

bladder drainage in adults. 

Infectious Diseases Group 

1. Jutte PC, Loenhout-Rooyackers JH van. Routine surgery in addition to 

chemotherapy for treating spinal tuberculosis. 

Inflammatory Bowel Disease Group 

1. Ley M de, Vos R de, Hommes DW, Stokkers PC. Fish oil for induction of remission 

in ulcerative colitis. 

2. Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, Wit N de. Bulking agents, 

antispasmodic and antidepressant medication for the treatment of irritable bowel 

syndrome. 

3. Zijdenbos IL, Wit NJ de, Heijden GJ van der, Rubin G, Quartero AO. Psychological 

treatments for the management of irritable bowel syndrome. 

Injuries Group 

1. Molen HF van der, Lehtola MM, Lappalainen J, Hoonakker PLT, Hsiao H, Haslam R, 

et al. Interventions for preventing injuries in the construction industry. 

2. Oostrom SH van, Driessen MT, Vet HCW de, Franche R, Schonstein E, Loisel P, et 

al. Workplace interventions for preventing work disability. 

Lung Cancer Group 

1. Pijls-Johannesma M, De Ruysscher Dirk KM, Lambin P, Houben R, Rutten I, 

Vansteenkiste JF. Early versus late chest radiotherapy in patients with limitedstage 

small cell lung cancer. 

22


Menstrual Disorders and Subfertility Group 

1. Bayram N, Wely M van, Veen F van der. Pulsatile gonadotrophin releasing 

hormone for ovulation induction in subfertility associated with polycystic ovary 

syndrome. 

2. Bayram N, Wely M van, Veen F van der. Recombinant FSH versus urinary 

gonadotrophins or recombinant FSH for ovulation induction in subfertility 

associated with polycystic ovary syndrome. 

3. Benschop L, Farquhar C, van der Poel N, Heineman MJ. Interventions for women 

with endometrioma prior to assisted reproductive technology. 

4. Bensdorp Alexandra, Cohlen Ben J, Heineman Maas Jan, Vanderkerchove Patrick. 

Intra-uterine insemination for male subfertility. 

5. Bontekoe S, Blake D, Heineman MJ, Williams EC, Johnson N. Adherence 

compounds in embryo transfer media for assisted reproductive technologies. 

6. Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid 

administration for assisted reproductive technology cycles. 

7. Boomsma CM, Heineman MJ, Cohlen BJ, Farquhar C. Semen preparation 

techniques for intrauterine insemination. 

8. Cantineau AEP, Cohlen BJ, Heineman MJ. Intrauterine insemination versus 

fallopian tube sperm perfusion for non-tubal infertility. 

9. Cantineau AEP, Cohlen BJ. Ovarian stimulation protocols (anti-oestrogens, 

gonadotrophins with and without GnRH agonists/antagonists) for intrauterine 

insemination (IUI) in women with subfertility. 

10. Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine 

insemination (IUI) in stimulated cycles for subfertile couples. 

11. Cantineau Astrid EP, Janssen MJ, Cohlen BJ. Synchronised approach for 

intrauterine insemination in subfertile couples. 

12. Derks RS, Farquhar C, Mol Ben WJ, Buckingham K, Heineman MJ. Techniques for 

preparation prior to embryo transfer. 

13. Evers JLH, Collins J, Clarke J. Surgery or embolisation for varicocele in subfertile 

men. 

14. Hajenius PJ, Mol F, Mol BWJ, Bossuyt PMM, Ankum WM, Veen F van der. 

Interventions for tubal ectopic pregnancy. 

15. Mochtar MH, Veen F van der, Ziech M, Wely M van, Musters A. Recombinant 

Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted 

reproductive cycles. 

16. Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, et al. Surgical 

approach to hysterectomy for benign gynaecological disease. 

17. Poel van der N, Farquhar C, Abou-Setta AM, Benschop L, Heineman MJ. Soft 

versus firm catheters for intrauterine insemination. 

18. Rumste MME van, Evers JLH, Farquhar CM. Intra-cytoplasmic sperm injection 

versus conventional techniques for oocyte insemination during in vitro fertilisation 

in patients with non-male subfertility. 

19. Smulders B, van Oirschot SM, Farquhar C, Rombauts L, Kremer Jan AM. Oral 

contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation 

protocols for women undergoing assisted reproductive techniques 

20. Twisk M, Mastenbroek S, Wely M van, Heineman MJ, Veen F van der, Repping S, 

Brown J. Preimplantation genetic screening for abnormal number of chromosomes 

(aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. 

21. Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ, te Velde E. Intra-uterine 

insemination for unexplained subfertility. 

23


22. Westergaard LW, Bossuyt PMM, Veen F van der, Wely M van. Human menopausal 

gonadotropin versus recombinant follicle stimulation hormone for ovarian 

stimulation in assisted reproductive cycles. 

23. Youssef Mohamed AFM, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, 

et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in 

antagonist assisted reproductive technology cycles. 

24. Youssef Mohamed AFM, Al-Inany HG, Evers Johannes LH, Aboulghar M. Intravenous 

fluids preventing severe ovarian hyperstimulation syndrome. 

Metabolic and Endocrine Disorders Group 

1. Goudswaard AN, Furlong NJ, Valk GD, Stolk RP, Rutten GEHM. Insulin 

monotherapy versus combinations of insulin with oral hypoglycaemic agents in 

patients with type 2 diabetes mellitus. 

2. Laar FA van de, Lucassen PLBJ, Akkermans RP, Lisdonk EH van de, Rutten GEHM, 

Weel C van. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. 

3. Laar FA van de, Lucassen PLBJ, Akkermans RP, Lisdonk EH van de, Grauw WJC 

de. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or 

impaired fasting blood glucose. 

4. Priebe MG, Binsbergen JJ van, Vos R de, Vonk RJ. Whole grain foods for the 

prevention of type 2 diabetes mellitus. 

5. Vermeire E, Wens J, Royen P van, Biot Y, Hearnshaw H, Lindenmeyer A. 

Interventions for improving adherence to treatment recommendations in people 

with type 2 diabetes mellitus. 

6. Welschen LMC, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WAB, 

Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes 

mellitus who are not using insulin. 

Movement Disorders Group 

1. Hilten JJ van, Ramaker CC, Stowe R, Ives N. Bromocriptine versus levodopa in 

early Parkinson's disease. 

2. Hilten JJ van, Ramaker CC, Stowe R, Ives N. Bromocriptine/levodopa combined 

versus levodopa alone for early Parkinson's disease. 

3. Ramaker C, Beek WJT van de, Finken MJJ, Hilten JJ van. Bromocriptine for 

levodopa-induced motor complications in Parkinson's disease. 

4. Smeulders MJC, Coester A, Kreulen M. Surgical treatment for the thumb-in-palm 

deformity in patients with cerebral palsy. 

Multiple Sclerosis Group 

1. Koch MW, Polman SKL, Uyttenboogaart M, Keyser J de. Treatment of seizures in 

multiple sclerosis. 

2. Rietberg MB, Brooks D, Uitdehaag BMJ, Kwakkel G. Exercise therapy for multiple 

sclerosis. 

3. Steultjens EMJ, Dekker J, Bouter LM, Cardol M, Ende CHM van den, Nes J van de. 

Occupational therapy for multiple sclerosis. 

24

Musculoskeletal Group 


1. Brouwer RW, van Raaij TM, Jakma TSC, Verhagen AP, Verhaar JAN, Bierma- 

Zeinstra SMA. Braces and orthoses for treating osteoarthritis of the knee. 

2. Brouwer RW, Raaij TM van, Bierma-Zeinstra SMA, Verhagen AP, Jakma TSC, 

Verhaar JAN. Osteotomy for treating knee osteoarthritis. 

3. Hurkmans E, van der Giesen FJ, Vliet Vlieland TPM, Schoones J, Ende ECHM van 

den. Dynamic exercise programs (aerobic capacity and/or muscle strength 

training) in patients with rheumatoid arthritis. 

4. Jacobs W, Andersen PG, Limbeek J van, Wymenga AAB. Mobile bearing vs fixed 

bearing prostheses for total knee arthroplasty for post-operative functional status 

in patients with osteoarthritis and rheumatoid arthritis. 

5. Jacobs W, Clement DJ, Wymenga AB. Retention versus sacrifice of the posterior 

cruciate ligament in total knee replacement for treatment of osteoarthritis and 

rheumatoid arthritis. 

6. Janssens HJ, Lucassen PLBJ, Laar FA van der, Janssen M, Lisdonk EH van de. 

Systemic corticosteroids for acute gout. 

7. Peters-Veluthamaningal C, Windt DAWM van der, Winters JC, Meyboom-de Jong 

B. Corticosteroid injection for de Quervain’s tenosynovitis. 

8. Peters-Veluthamaningal C, Windt DAWM van der, Winters JC, Meyboom-de Jong 

B. Corticosteroid injection for trigger finger in adults. 

9. Steultjens EMJ, Dekker J, Bouter LM, Schaardenburg D van, Kuyk MAH van, Ende 

CHM van den. Occupational therapy for rheumatoid arthritis. 

10. Struijs PAA, Smidt N, Arola H, Dijk CN van, Buchbinder R, Assendelft WJJ. Orthotic 

devices for the treatment of tennis elbow. 

11. Takken T, Brussel M van, Engelbert RHH, Net JJ van der, Kuis W, Helders PPJM. 

Exercise therapy in juvenile idiopathic arthritis. 

12. Takken T, Net J van der, Helders PJM. Methotrexate for treating juvenile idiopathic 

arthritis. 

13. Verhagen AP, Bierma-Zeinstra SMA, Boers M, Cardoso JR, Lambeck J, Bie RA de, 

Vet HCW de. Balneotherapy for osteoarthritis. 

14. Verhagen AP, Bierma-Zeinstra SMA, Boers M, Cardoso JR, Lambeck J, Bie RA de, 

Vet HCW de. Balneotherapy for rheumatoid arthritis. 

Neonatal Group 

1. Cools F, Offringa M. Neuromuscular paralysis for newborn infants receiving 

mechanical ventilation. 

2. Cools Filip , Henderson Smart David J , Offringa Martin , Askie Lisa M. Elective 

high frequency oscillatory ventilation versus conventional ventilation for acute 

pulmonary dysfunction in preterm infants 

3. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in 

neonates. 

Neuromuscular Disease Group 

1. van Alfen Nens, van Engelen Baziel GM, Hughes Richard AC. Treatment for 

idiopathic and hereditary neuralgic amyotrophy (brachial neuritis) 

2. Bosboom Wendy MJ, Vrancken Alexander FJE, van den Berg LH, Wokke John HJ, 

Iannaccone ST. Drug treatment for spinal muscular atrophy type I. 

3. Bosboom Wendy MJ, Vrancken Alexander FJE, van den Berg LH, Wokke John HJ, 

Iannaccone ST. Drug treatment for spinal muscular atrophy types II and III. 

25


4. Eftimov F, Winer JB, Vermeulen M, Haan R de, Schaik IN van. Intravenous 

immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. 

5. Hermans G, Jonge B De, Bruyninckx F, Berghe G Van den. Interventions for 

preventing critical illness polyneuropathy and critical illness myopathy. 

6. Schaik IN van, Berg LH van den, Haan R de, Vermeulen M. Intravenous 

immunoglobulin for multifocal motor neuropathy. 

7. Scholten RJPM, Molen AM van der, Uitdehaag BMJ, Bouter LM, Vet HCW de. 

Surgical treatment options for carpal tunnel syndrome. 

8. Trip J, Drost GG, van Engelen Baziel GM, Faber CG. Drug treatment for myotonia. 

9. Van Veen Natasja HJ, Schreuders Ton AR, Theuvenet WJ, Agrawal A, Richardus 

JH. Decompressive surgery for treating nerve damage in leprosy. 

10. Van Veen NHJ, Nicholls PG, Smith WCS, Richardus JH. Corticosteroids for treating 

nerve damage in leprosy. 

11. Voet NBM, Kooi EL van der, Riphagen I, Lindeman E, Engelen BGM van, Geurts 

ACH. Strength training and aerobic exercise training for muscle disease. 

12. Vrancken AFJE, Schaik IN van, Hughes RAC, Notermans NC. Drug therapy for 

chronic idiopathic axonal polyneuropathy. 

13. Vrancken AFJE, Hughes RAC, Said G, Wokke JHJ, Notermans NC. 

Immunosuppressive treatment for non-systemic vasculitic neuropathy. 

Oral Health Group 

1. Mettes DTG, Nienhuijs MEL, Sanden WJM van der, Verdonschot EH, Plasschaert 

AJM. Interventions for treating asymptomatic impacted wisdom teeth in 

adolescents and adults. 

Pain, Palliative and Supportive Care Group 

1. Goedendorp MM, Gielissen Marieke FM, Verhagen Constantijn AHHV, Bleijenberg 

G. Psychosocial interventions for reducing fatigue during cancer treatment in 

adults. 

Peripheral Vascular Diseases Group 

1. Backer TLM de, Bogaert MG, Stichele RH vander. Buflomedil for intermittent 

claudication. 

2. Backer TLM de, Stichele RH vander, Lehert P, Bortel L van. Naftidrofuryl for 

intermittent claudication. 

3. Bendermacher BLW, Willigendael EM, Teijink JAW, Prins MH. Supervised exercise 

therapy versus non-supervised exercise therapy for intermittent claudication. 

4. Cohn D, Vansenne F, Borgie C de, Middeldorp S. Thrombophilia testing for 

prevention of recurrent venous thromboembolism. 

5. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of 

the leg. 

6. Dongen CJ van, MacGillavry MR, Prins MH. Once versus twice daily low molecular 

weight heparin for the initial treatment of venous thromboembolism. 

7. Erkens Petra MG, Prins MH. Fixed dose subcutaneous low molecular weight 

heparins versus adjusted dose unfractionated heparin for venous 

thromboembolism. 

8. Heijden JF van der, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or lowmolecular-weight 

heparin for the long term treatment of symptomatic venous 

thromboembolism. 

26


9. Hutten BA, Prins MH. Duration of treatment with vitamin K antagonists in 

symptomatic venous thromboembolism. 

10. Kolbach DN, Sandbrink MWC, Prins MH, Neumann MHAM. Compression therapy for 

treating stage I and II (Widmer) post-thrombotic syndrome. 

11. Kolbach DN, Sandbrink MWC, Hamulyak K, Prins MH, Neumann HAM. Nonpharmaceutical 

measures for prevention of post-thrombotic syndrome. 

12. Nicolaï Saskia PA, Kruidenier LM, Bendermacher Bianca LW, Prins MH, Teijink Joep 

AW. Ginkgo biloba for intermittent claudication. 

13. Testroote M, Stigter WAH, Visser DC de, Janzing HMJ. Low molecular weight 

heparin for prevention of venous thromboembolism in patients with lower-leg 

immobilization. 

14. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic 

critical leg ischaemia. 

Pregnancy and Childbirth Group 

1. Alexander S, Boulvain M, Ceysens G, Haelterman E, Zhang W. Repeat digital 

cervical assessment in pregnancy for identifying women at risk of preterm labour. 

2. Besselink DE, Farquhar C, Kremer Jan AM, Marjoribanks J, O'Brien PA. Cervical 

insemination versus intra-uterine insemination of donor sperm for subfertility. 

3. Ceysens G, Rouiller D, Boulvain M. Exercise for diabetic pregnant women. 

4. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for 

treating recurrent miscarriage in women without antiphospholipid syndrome. 

5. van Lonkhuijzen Luc, Stekelenburg Jelle, van Roosmalen Jos. Maternity waiting 

facilities for improving maternal and neonatal outcome in low-resource countries. 

6. Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists 

for inhibiting preterm birth after threatened preterm labour. 

7. Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for 

inhibiting preterm labour. 

Schizophrenia Group 

1. Liu X, Haan S de. Chlorpromazine dose for people with schizophrenia. 

Skin Group 

1. Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP. 

Interventions for bullous pemphigoid. 

2. Kirtschig G, Murrell DF, Wojnarowska F, Khumalo NP. Interventions for mucous 

membrane pemphigoid and epidermolysis bullosa acquisita. 

3. Koning S, Verhagen AP, Suijlekom-Smit LWA van, Morris AD, Butler C, Wouden JC 

van der. Interventions for Impetigo. 

4. Van Veen Natasja HJ , Lockwood Diana NJ, van Brakel Wim H , Ramirez Jr Jose , 

Richardus Jan Hendrik. Interventions for erythema nodosum leprosum. 

5. Van der Wouden JC, van der Sande R, van Suijlekom-Smit Lisette WA, Berger M, 

Butler C, Koning S. Interventions for cutaneous molluscum contagiosum. 

6. Zuuren EJ van, Graber MA, Hollis S, Chaudhry MMC, Gupta AK, Gover MD. 

Interventions for rosacea. 

27

Stroke Group 


1. Algra A, Schryver ELLM de, Gijn J van, Kappelle LJ, Koudstaal PJ. Oral 

anticoagulants versus antiplatelet therapy for preventing further vascular events 

after transient ischaemic attack or minor stroke of presumed arterial origin. 

2. Den Hertog Heleen M , van der Worp H Bart , Tseng Mei Chiun , Dippel Diederik 

WJ Cooling therapy for acute stroke. 

3. Dorhout Mees SM, Bergh WM van den, Algra A, Rinkel GJE. Antiplatelet therapy 

for aneurysmal subarachnoid haemorrhage. 

4. Dorhout Mees SM, Rinkel GJE, Feigin VL, Algra A, Bergh WM van den, Vermeulen 

M, Gijn J van. Calcium antagonists for aneurysmal subarachnoid haemorrhage. 

5. Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. 

6. Rinkel GJE, Feigin VL, Algra A, Gijn J van. Circulatory volume expansion therapy 

for aneurysmal subarachnoid haemorrhage. 

7. Roos YBWEM, Rinkel GJE, Vermeulen M, Algra A, Gijn J van. Antifibrinolytic 

therapy for aneurysmal subarachnoid haemorrhage. 

8. Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with 

nonrheumatic atrial fibrillation and a history of stroke or transient ischemic 

attacks. 

9. Saxena R, Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing 

stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or 

transient ischemic attack. 

10. Schaaf I van der, Algra A, Wermer M, Molyneux A, Clarke MJ, Gijn J van, Rinkel 

GJE. Endovascular coiling versus neurosurgical clipping for patients with 

aneurysmal subarachnoid haemorrhage. 

11. Schryver De ELLM, Algra A, Gijn J van. Dipyridamole for preventing stroke and 

other vascular events in patients with vascular disease. 

12. Stam J, Bruijn SFTM de, DeVeber G. Anticoagulation for cerebral sinus thrombosis. 

Tobacco Addiction Group 

1. Reda AA, Kaper J, Fikretler H, Severens JL, Schayck OP van. Healthcare financing 

systems for increasing the use of tobacco dependence treatment. 

Upper Gastrointestinal and Pancreatic Diseases Group 

1. Homs MYV, Gaast A van de, Siersema PD, Steyerberg EW, Kuipers EJ. 

Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal 

junction. 

2. Pinxteren B van, Sigterman KE, Bonis PA, Lau J, Numans ME. Short-term 

treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics 

for gastro-oesophageal reflux disease-like symptoms and endoscopy negative 

reflux disease. 

Wounds Group 

1. Dorresteijn Johannes AN, Kriegsman Didi MW, Valk GD. Complex interventions for 

preventing diabetic foot ulceration. 

2. Dorresteijn Johannes AN, Kriegsman Didi MW, Assendelft Willem JJ, Valk GD. 

Patient education for preventing diabetic foot ulceration. 

3. Eskes A, Ubbink DT, Lubbers M, Lucas C, Vermeulen H. Hyperbaric oxygen 

therapy for treating acute surgical and traumatic wounds. 

28


4. Rijen M van, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing 

Staphylococcus aureus infections in nasal carriers. 

5. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for 

preventing wound infection. 

6. Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H. Topical negative 

pressure for treating chronic wounds. 

7. Vermeulen H, Ubbink DT, Goossens A, Vos R de, Legemate D. Dressings and 

topical agents for surgical wounds healing by secondary intention. 

8. Vermeulen H, Hattem JM van, Storm-Versloot MN, Ubbink DT. Topical silver for 

treating infected wounds. 

29


30


Publications relevant to The Cochrane Collaboration and Evidence-Based 

Medicine 

INTERNATIONAL PUBLICATIONS 

Donnelly JP, Leeflang MM. Galactomannan detection and diagnosis of invasive 

aspergillosis. Clin Infect Dis 2010 Apr 1;50(7):1070-1. 

Elbers GM, Rietberg M, Wegen E van, Verhoef J, Terwee C, Kramer SF, Kwakkel G. 

The assessment of fatigue in multiple sclerosis, Parkinson’s disease and stroke: a 

systematic review of measurement properties. Cochrane Database of Systematic 

Reviews Suppl 1-166. DOI:10.1002/14651858.CD000002. 

Hooft L, Van Enst WA, Scholten RJPM. Extending the search to find ongoing and 

unpublished trials: A survey of methods and results of Cochrane reviews, 2010. 

Cochrane Database of Systematic Reviews Suppl 1-166. 

DOI:10.1002/14651858.CD000002. 

Hyde C, Leeflang MM, Davenport C, Garside R, Bossuyt PM, Deeks J. Investigating 

and improving the understanding of Cochrane Diagnostic test accuracy reviews 

(DTARs). Cochrane Database of Systematic Reviews Suppl 1-166. 

DOI:10.1002/14651858.CD000002. 

Kramer SF, Langendam MW, Elbers GM. Differences in addressing heterogeneity 

in Cochrane reviews. Cochrane Database of Systematic Reviews Suppl 1-166. 

DOI:10.1002/14651858.CD000002. 

Langendam MW, Hooft L, Scholten RJPM. GRADE: reasons for downgrading the 

quality of evidence in recent Cochrane Reviews. Cochrane Database of Systematic 

Reviews Suppl 1-166. DOI:10.1002/14651858.CD000002. 

Langendam MW, Kuijpers T, De Beer H, Kremer L. Tips and tricks for understanding 

and using SR results 17: an introduction to the GRADE approach; rating the quality of 

evidence for an intervention. Evidence-Based Child Health 2010;5:537-540. 

Leclerq E, Leeflang MM, Dalen EC van. Validation of a PubMed search filter for 

identifying studies including children. Cochrane Database of Systematic Reviews 

Suppl 1-166. DOI:10.1002/14651858.CD000002. 

Leeflang MM, Hooft L, Reitsma J, Deeks J, Bossuyt PM. Bivariate meta-analysis of 

predictive values. Cochrane Database of Systematic Reviews Suppl 1-166. 

DOI:10.1002/14651858.CD000002. 

Leeflang MM, Hooft L, Reitsma J, Bossuyt PM. Sensitivity and specificity rarely 

vary with prevalence. Cochrane Database of Systematic Reviews Suppl 1-166. 

DOI:10.1002/14651858.CD000002. 

Oude Rengerink K, Opmeer BC, Logtenberg SL, Hooft L, Bloemenkamp KW, Haak 

MC, et al. IMproving PArticipation of patients in Clinical Trials--rationale and design of 

IMPACT. BMC Med Res Methodol 2010 Sep 27;10:85. 

Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a 

rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol 

2010 May;162(5):964-73. 

31


Sparreboom M, van Schoonhoven J, van Zanten BG, Scholten RJ, Mylanus EA, 

Grolman W, et al. The effectiveness of bilateral cochlear implants for severe-toprofound 

deafness in children: a systematic review. Otol Neurotol 2010 

Sep;31(7):1062-71. 

van Loendersloot LL, van Wely M, Limpens J, Bossuyt PM, Repping S, van der Veen 

F. Predictive factors in in vitro fertilization (IVF): a systematic review and metaanalysis. 

Hum Reprod Update 2010 Nov;16(6):577-89. 

van Dijk N, Hooft L, Wieringa-de Waard WM. What are the barriers to residents' 

practicing evidence-based medicine? A systematic review. Acad Med 2010 

Jul;85(7):1163-70. 

van Leeuwen M, Opmeer BC, Yilmaz Y, Limpens J, Serlie MJ, Mol BW. Accuracy of 

the random glucose test as screening test for gestational diabetes mellitus: a 

systematic review. Eur J Obstet Gynecol Reprod Biol 2010 Dec 1. 

COCHRANE PROTOCOLS AND REVIEWS 

Eftimov F, Lunn MPT, Leeflang MMG, Schaik IN van. Anti-GM1 antibody testing for 

multifocal motor neuropathy. 

Langendam MW, Hooft L, De Vries H, Wentholt IM, Mudde AH, Burt AL, Scholten 

RJPM. Continuous glucose monitoring systems for type 1 diabetes mellitus. 

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, 

Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM. Galactomannan detection for 

invasive aspergillosis in immunocompromized patients. 

Leeflang MM, McDonald S, Scholten RJ, Rutjes A, Reitsma JJB. Search strategies 

to identify diagnostic accuracy studies in MEDLINE and EMBASE. 

McGuire W, Fowlie PW, Reitsma JB. Clinical assessment for diagnosing congenital 

heart disease in newborn infants with Down syndrome. 

Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Non-steroidal antiinflammatory 

drugs for low back pain. 

Romme JJCM, Black CN, Colman N, Scholten RJ, Reitsma JB, Wieling W, Van Dijk 

N. Drugs and pacemakers for neurally mediated reflex syncope. 

Scholten RJ, Mink van der Molen A, Uitdehaag BM, Bouter LM, de Vet HC. Surgical 

treatment options for carpal tunnel syndrome. 

Vasiliadis HS, Shrier I, Salanti G, Scholten RJ. Endoscopic release for carpal tunnel 

syndrome. 

Velema M, Hooft L, Lebwohl M, Spuls PI. Interventions for nail psoriasis. 

Vink AC, Bruinsma MS, Scholten RJ. Music therapy in the care of people with 

dementia. 

Vroon P, Weert HCPM van, Scholten RJ. Interventions for ganglion cysts in adults. 

32

NATIONAL PUBLICATIONS 


Langendam MW, Pijnenburg MW, de Jongste JC, Hooft L, Scholten RJ, Boluyt N. 

[Treatment of children with asthma based on exhaled nitrogen monoxide: added 

value of nitrogen monoxide measurements has not yet been demonstrated]. Ned 

Tijdschr Geneeskd 2010;154:A1804. 

“In het kort” (short summaries of Cochrane reviews published in the Nederlands 

Tijdschrift voor Geneeskunde) 

Elbers GM, Kramer SF. Exercise for osteoarthritis of the hip [Effectiviteit 

fysiotherapie bij artrose niet aangetoond]. Ned Tijdschr Geneeskd 2010;154:A1590 

Elbers GM, Van Enst WA. Bicycle helmet legislation [Helmplicht voor fietsers]. Ned 

Tijdschr Geneeskd 2010;154:A2728 

Hooft L, Jonge A de. Restricting oral fluid and food intake during labour [Eten en 

drinken tijdens de partus]. Ned Tijdschr Geneeskd 2010:154:A2429 

Hooft L, Middeldorp S. First-line drugs for hypertension [Middel van eerste keus voor 

de behandeling van hypertensie]. Ned Tijdschr Geneeskd 2010;154:A1590 

Hooft L, Opstelten W. Family therapy for anorexia nervosa [Gezinstherapie anorexia 

nervosa]. Ned Tijdschr Geneeskd 2010:154:A2428 

Kramer SF, Kok W. Exercise based rehabilitation for heart failure [De effectiviteit van 

hartrevalidatie bij hartfalen]. Ned Tijdschr Geneeskd 2010;154:A2409 

Kramer SF, Langendam MW. Topical rubefacients for acute and chronic pain in 

adults [Effect van wrijfmiddelen tegen spierpijn niet duidelijk aangetoond]. Ned 

Tijdschr Geneeskd 2010;154:A1591 

Kramer SF, Verbeek J. Caffeine for the prevention of injuries and errors in shift 

workers [Effect caffeine bij ploegendienstwerkers onduidelijk]. Ned Tijdschr Geneeskd 

2010;154:A2621 

Langendam MW, Scherjon S. Ultrasound for fetal assessment in early pregnancy 

[Routinematig uitgevoerde echografisch onderzoek in de vroege zwangerschap lijkt 

nuttig]. Ned Tijdschr Geneesk 2010;154:A2399 

Scholten RJPM, Renders CM. Social norms interventions to reduce alcohol misuse in 

University or College students [Interventies gericht op de sociale drinknorm ter 

vermindering van alcoholmisbruik onder studenten]. Ned Tijdschr Geneeskd 

2010;154;1648 

Van Enst WA, Elbers GM. Aspirin with or without an antiemetic for acute migraine 

[Acetylsalisylzuur effectief bij migraine]. Ned Tijdschr Geneeskd 2010;154:A2415 

33

REPORTS 


Kramer SF, Elbers GE, Van Enst WA, Langendam MW, Hooft L, Spijker R, 

Scholten RJPM. Physiotherapy interventions for osteoporosis. An overview of 

systematic reviews. Dutch Cochrane Centre, November 2010. 

Kramer SF, Elbers GE, Langendam MW, Spijker R, Hooft L, Scholten RJPM. 

Physiotherapy interventions for osteoarthritis. An overview of systematic reviews. 

Dutch Cochrane Centre, June 2010. 

Kramer SF, Riemsma R, Elbers GMH, Limpens CEJM, Mol MAE, Kleijnen J, 

Scholten RJPM. Behandeling van kinderen met astma die onvoldoende reageren op 

inhalatiesteroïden. Dutch Cochrane Centre, July 2010. 

Langendam MW, Hooft L, Kramer SF, Van Enst WA, Scholten RJPM. Bariatric 

surgery: a scoping review. Dutch Cochrane Centre, July 2010. 

Langendam MW, Hooft L, Mudde AH, Vries Hans de, Luijf Y, Limpens CEJM, 

Scholten RJPM. Continuous glucose monitoring for diabetes mellitus. A systematic 

review. Dutch Cochrane Centre, February 2010. 

34


Participation in Cochrane Entities 

Roy Elbers 

• Airways Group 

• Movement Disorders Group 

• Patient Reported Outcomes Methods Group 

Lotty Hooft 


• Bias Methods Group 

• Breast Cancer Group 

• Childhood Cancer Group 

• Continental Europe Support Unit 

• Developmental, Psychosocial and Learning Problems Group 

• Diagnostic Test Accuracy Working Group 

• Movement Disorders Group 

• Prognosis Methods Group 

• Screening and Diagnostic Tests Methods Group 

• Skin Group 

• Thomas C Chalmers Award Committee 

• Working Group on Best Practice for Clinical Trials Registers (BPG) of the 

International Clinical Trials Registry Platform (ICTRP) (Chair) 

Sharon Kramer 


• Bone Joint and Muscle Trauma Group 


• Trainers’ Network 

Miranda Langendam 

• Cochrane Collaboration Strategic Partnerships Working Group 

• Applicability and Recommendations Methods Group 

• GRADE Working Group 

• Metabolic and Endocrine Disorders Group 

• Prognosis Methods Group 

• Trainers’ Network 

Mariska Leeflang 


• Consumer Network 



• Diagnostic Test Accuracy Editorial Team 

• Hepato-Biliary Group 

• HIV/AIDS Group 

• Infectious Diseases Group 

35

• Methodology Review Group 

• Methods Board 

• Methods Executive 

• Neuromuscular Disease Group 

• Renal Group 


• Screening and Diagnostic Tests Methods Group (Co-Convenor) 

Jacqueline Limpens 

• CENTRAL forum 

• Consumer Network (Advisory Board member) 

• Information Retrieval Methods Group 


• TSCs’ Forum 

Rob Scholten 


• Back Group 

• Bone Joint and Muscle Trauma Group 

• Centre Directors’ Executive 

• Cochrane Collaboration Steering Group (until October 17) 

• Cochrane Collaboration Trading Company Director 


• Dementia and Cognitive Improvement Group 

• Developmental, Psychosocial and Learning Problems Group 


• Diagnostic Test Accuracy Editorial Team 

• Heart Group 

• Information Management System Group (until October 17) 

• Methodology Review Group 

• Monitoring and Registration Group (until June 17) 

• Neuromuscular Disease Group 

• Screening and Diagnostic Tests Methods Group 

• Statistical Methods Group 

• Thomas C Chalmers Award Committee 

René Spijker 

• Trial Search Coordinators’ Executive 

• TSCs’ Forum 

36

2010 - Dutch Cochrane Centre - The Cochrane Collaboration

Create successful ePaper yourself

Delete template?

Save as template?